Complement and the prothrombotic state
Review article
[키워드] Activation
affecting
Anticoagulant
antiplatelet
approval
Atypical
Autoimmune
blood cell
catastrophic
CD55
CD59
clinical evidence
Clinical management
complement
Complement pathway
concerning
condition
deficiency
diagnostic
disease
etiology
Ex vivo
feature
hemolytic anemia
Hemostasis
high mortality
Host
humans
Hyperactivation
in vitro
inhibition
inhibitor
life-threatening
molecular interaction
morbidity
Occurrence
paroxysmal nocturnal hemoglobinuria
Patient
Prevent
protein-losing enteropathy
prothrombotic
prothrombotic state
Regulation
Regulatory
responsible
syndrome
the disease
therapeutic
Therapies
therapy
thrombosis
thrombotic event
treated
uremic syndrome
[DOI] 10.1182/blood.2020007206 [Article Type] Review article
[DOI] 10.1182/blood.2020007206 [Article Type] Review article